103 related articles for article (PubMed ID: 21638052)
1. Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing.
Brandão RD; van Roozendaal K; Tserpelis D; Gómez García E; Blok MJ
Breast Cancer Res Treat; 2011 Oct; 129(3):971-82. PubMed ID: 21638052
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients.
Lee E; McKean-Cowdin R; Ma H; Chen Z; Van Den Berg D; Henderson BE; Bernstein L; Ursin G
Breast Cancer Res; 2008; 10(1):R19. PubMed ID: 18284688
[TBL] [Abstract][Full Text] [Related]
3. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from "Uncertain Significance" to "Pathogenic" based on minigene assays and clinical evidence.
Ning Y; Zhang Y; Tian T; Chen Y; Wang J; Lei K; Cui Z
J Cancer Res Clin Oncol; 2024 Feb; 150(2):62. PubMed ID: 38300310
[TBL] [Abstract][Full Text] [Related]
4. BRCA2 T2722R is a deleterious allele that causes exon skipping.
Fackenthal JD; Cartegni L; Krainer AR; Olopade OI
Am J Hum Genet; 2002 Sep; 71(3):625-31. PubMed ID: 12145750
[TBL] [Abstract][Full Text] [Related]
5. Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
Thomassen M; Mesman RLS; Hansen TVO; Menendez M; Rossing M; Esteban-Sánchez A; Tudini E; Törngren T; Parsons MT; Pedersen IS; Teo SH; Kruse TA; Møller P; Borg Å; Jensen UB; Christensen LL; Singer CF; Muhr D; Santamarina M; Brandao R; Andresen BS; Feng BJ; Canson D; Richardson ME; Karam R; Pesaran T; LaDuca H; Conner BR; Abualkheir N; Hoang L; Calléja FMGR; Andrews L; James PA; Bunyan D; Hamblett A; Radice P; Goldgar DE; Walker LC; Engel C; Claes KBM; Macháčková E; Baralle D; Viel A; Wappenschmidt B; Lazaro C; Vega A; ; Vreeswijk MPG; de la Hoya M; Spurdle AB
Hum Mutat; 2022 Dec; 43(12):1921-1944. PubMed ID: 35979650
[TBL] [Abstract][Full Text] [Related]
6. A novel
Colombo M; Mondini P; Minenza E; Foglia C; Mosconi A; Molica C; Pistola L; Ludovini V; Radice P
Front Oncol; 2023; 13():1102184. PubMed ID: 37025588
[TBL] [Abstract][Full Text] [Related]
7. Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant.
Block I; Mateu-Regué À; Do TTN; Miceikaite I; Sdogati D; Larsen MJ; Hao Q; Nielsen HR; Boonen SE; Skytte AB; Jensen UB; Høffding LK; De Nicolo A; Viel A; Tudini E; Parsons MT; Hansen TVO; Rossing M; Kruse TA; Spurdle AB; Thomassen M
Breast Cancer Res; 2024 Jan; 26(1):6. PubMed ID: 38195559
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the
Sanoguera-Miralles L; Valenzuela-Palomo A; Bueno-Martínez E; Llovet P; Díez-Gómez B; Caloca MJ; Pérez-Segura P; Fraile-Bethencourt E; Colmena M; Carvalho S; Allen J; Easton DF; Devilee P; Vreeswijk MPG; de la Hoya M; Velasco EA
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33333735
[TBL] [Abstract][Full Text] [Related]
9. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Lindor NM; Guidugli L; Wang X; Vallée MP; Monteiro AN; Tavtigian S; Goldgar DE; Couch FJ
Hum Mutat; 2012 Jan; 33(1):8-21. PubMed ID: 21990134
[TBL] [Abstract][Full Text] [Related]
10. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
[TBL] [Abstract][Full Text] [Related]
11. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
Houdayer C; Caux-Moncoutier V; Krieger S; Barrois M; Bonnet F; Bourdon V; Bronner M; Buisson M; Coulet F; Gaildrat P; Lefol C; Léone M; Mazoyer S; Muller D; Remenieras A; Révillion F; Rouleau E; Sokolowska J; Vert JP; Lidereau R; Soubrier F; Sobol H; Sevenet N; Bressac-de Paillerets B; Hardouin A; Tosi M; Sinilnikova OM; Stoppa-Lyonnet D
Hum Mutat; 2012 Aug; 33(8):1228-38. PubMed ID: 22505045
[TBL] [Abstract][Full Text] [Related]
13. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
[TBL] [Abstract][Full Text] [Related]
14. Targeted RNA sequencing reveals the deep complexity of the human transcriptome.
Mercer TR; Gerhardt DJ; Dinger ME; Crawford J; Trapnell C; Jeddeloh JA; Mattick JS; Rinn JL
Nat Biotechnol; 2011 Nov; 30(1):99-104. PubMed ID: 22081020
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes.
Acedo A; Sanz DJ; Durán M; Infante M; Pérez-Cabornero L; Miner C; Velasco EA
Breast Cancer Res; 2012 May; 14(3):R87. PubMed ID: 22632462
[TBL] [Abstract][Full Text] [Related]
16. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.
Nykamp K; Anderson M; Powers M; Garcia J; Herrera B; Ho YY; Kobayashi Y; Patil N; Thusberg J; Westbrook M; ; Topper S
Genet Med; 2017 Oct; 19(10):1105-1117. PubMed ID: 28492532
[TBL] [Abstract][Full Text] [Related]
17. Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.
Wappenschmidt B; Becker AA; Hauke J; Weber U; Engert S; Köhler J; Kast K; Arnold N; Rhiem K; Hahnen E; Meindl A; Schmutzler RK
PLoS One; 2012; 7(12):e50800. PubMed ID: 23239986
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Castéra L; Krieger S; Rousselin A; Legros A; Baumann JJ; Bruet O; Brault B; Fouillet R; Goardon N; Letac O; Baert-Desurmont S; Tinat J; Bera O; Dugast C; Berthet P; Polycarpe F; Layet V; Hardouin A; Frébourg T; Vaur D
Eur J Hum Genet; 2014 Nov; 22(11):1305-13. PubMed ID: 24549055
[TBL] [Abstract][Full Text] [Related]
19. Classification of missense substitutions in the BRCA genes: a database dedicated to Ex-UVs.
Vallée MP; Francy TC; Judkins MK; Babikyan D; Lesueur F; Gammon A; Goldgar DE; Couch FJ; Tavtigian SV
Hum Mutat; 2012 Jan; 33(1):22-8. PubMed ID: 21990165
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
